Olmesartan
Showing 1 - 25 of 166
Essential Arterial Hypertension Trial (Olmesartan Medoxomil 20mg + Chlorthalidone 12,5mg, Olmesartan medoxomil 20mg +
Not yet recruiting
- Essential Arterial Hypertension
- Olmesartan Medoxomil 20mg + Chlorthalidone 12,5mg
- +2 more
- (no location specified)
Aug 3, 2022
Arterial Hypertension Trial (Olmesartan medoxomil 40mg + chlorthalidone 12,5mg, Olmesartan medoxomil 40mg + chlorthalidone 25mg,
Not yet recruiting
- Arterial Hypertension
- Olmesartan medoxomil 40mg + chlorthalidone 12,5mg
- +3 more
- (no location specified)
Aug 3, 2022
Angiotensin/Renin/Aldosterone Hypertension, Hypertension, Diabetes, Type 2 Trial in Seongnam (Olmesartan)
Recruiting
- Angiotensin/Renin/Aldosterone Hypertension
- +2 more
- Olmesartan
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Aug 16, 2022
Hypertension, Hypertension,Essential Trial (fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg, Isolated drugs Olmesartan
Not yet recruiting
- Hypertension
- Hypertension,Essential
- fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg
- Isolated drugs Olmesartan (20 mg or 40 mg) and Indapamide (1,5 mg)
- (no location specified)
Mar 17, 2022
Hypertension, Hyperlipidemias Trial in Seoul (Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg, Olmesartan 40
Completed
- Hypertension
- Hyperlipidemias
- Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg
- +2 more
-
Seoul, Korea, Republic ofSeoul national university bundang hospital
Dec 20, 2021
Improving Systolic BP and LDL-C Compared to Conventional
Not yet recruiting
- Hyperlipidemias
- Hypertension
- Rosuvastatin, Olmesartan Medoxomil
- (no location specified)
Jun 6, 2022
OLOMAX for Blood Pressure and Low-density Lipoprotein
Recruiting
- Hypertension
- Dyslipidemias
- Olmesartan Medoxomil/ Amlodipine Besylate/ Rosuvastatin Ca
-
Seoul, Korea, Republic ofSeoul St.Mary's Hospital
Dec 13, 2022
Essential Hypertension Trial in Shenzhen (Sacubatril Allisartan medoxomil, Olmesartan Medoxomil)
Recruiting
- Essential Hypertension
- Sacubatril Allisartan medoxomil
- Olmesartan Medoxomil
-
Shenzhen, Guangdong, ChinaShenzhen People' S Hospital
Aug 30, 2021
Therapeutic Effectiveness and Safety of Olomax Tab
Enrolling by invitation
- Hypertension
- Dyslipidemia
- Olmesartan Medoxomil
-
Hwaseong-si, Gyeonggi, Korea, Republic ofHallym University Dongtan Sacred Heart Hospital
Dec 21, 2021
Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino
Terminated
- Hypertension
- Amlodipine + Olmesartan medoxomil
-
San Fernando City, LA Union, Philippines
- +56 more
Jul 26, 2021
Hypertension Trial in Germany, Switzerland, United Kingdom (sacubitril/valsartan (LCZ696), olmesartan, to sacubitril/valsartan
Completed
- Hypertension
- sacubitril/valsartan (LCZ696)
- +4 more
-
Berlin, Germany
- +3 more
Dec 9, 2020
Healthy Adult Volunteers Trial in Seoul (Olmesartan, Dapagliflozin)
Completed
- Healthy Adult Volunteers
- Olmesartan
- Dapagliflozin
-
Seoul, Gwanak-gu, Korea, Republic ofH Plus Yangji Hospital
Aug 31, 2021
Coronavirus Disease 2019, COVID-19 Trial in Australia, India (Angiotensin Receptor Blockers, Placebo)
Completed
- Coronavirus Disease 2019
- COVID-19
- Angiotensin Receptor Blockers
- Placebo
-
Camperdown, New South Wales, Australia
- +21 more
Mar 2, 2022
Stroke, Ischemic Trial in Thessaloniki (Olmesartan, Nebivolol, No antihypertensive treatment)
Completed
- Stroke, Ischemic
- Olmesartan
- +2 more
-
Thessaloniki, GreeceAHEPA University Hospital
Jan 6, 2020
Bioequivalence Trial in Mont-Royal (Olmesartan Medoxomil/Hydrochlorothiazide 40 Mg/25 Mg film-coated tablets for oral use,
Unknown status
- Bioequivalence
- Olmesartan Medoxomil/Hydrochlorothiazide 40 Mg/25 Mg film-coated tablets for oral use
- Olmetec® Plus 40 Mg/25 Mg film-coated tablets for oral use
-
Mont-Royal, Quebec, CanadaAltasciences Company Inc.
Dec 2, 2019
Hypertension, COVID-19 Trial in Galway (Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor)
Suspended
- Hypertension
- COVID-19
- Thiazide or Thiazide-like diuretics
- +3 more
-
Galway, IrelandUniversity Hospital Galway
Jun 26, 2020
Hypertension, Dyslipidemia Trial in Seoul (Amlodipine/Olmesartan 10/40mg (Combination drug), Ezetimibe/Rosuvastatin
Unknown status
- Hypertension, Dyslipidemia
- Amlodipine/Olmesartan 10/40mg (Combination drug), Ezetimibe/Rosuvastatin 10/20mg(Combination drug)
- +2 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Nov 10, 2019
Hypertension Trial in Worldwide (Olmesartan, Amlodipine, Indapamide)
Recruiting
- Hypertension
- Olmesartan
- +4 more
-
Birmingham, Alabama
- +119 more
Jan 13, 2023
Bioequivalence Trial in Mont-Royal (Olmesartan Medoxomil 40 mg, Olmetec®)
Completed
- Bioequivalence
- Olmesartan Medoxomil 40 mg
- Olmetec®
-
Mont-Royal, Quebec, CanadaAltasciences Company Inc.
Jul 26, 2019
MRA and ARB Treatment in Screening of Primary Aldosteronism
Completed
- Primary Aldosteronism Due to Aldosterone Producing Adenoma
- canrenone 50-100 mg orally once a day
- olmesartan 10-20 mg orally once a day
-
Padova, ItalyDepartment of Medicine - DIMED, University of Padova, Italy
Dec 2, 2019
Sacubitril/Valsartan on Cardiac Function in Hypertensive
Recruiting
- Sacubitril/Valsartan
- +2 more
- Sacubitril / Valsartan Oral Tablet [Entresto]
- ACEI/ARB
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Aug 10, 2022